Companies / Lyell Immunopharma, Inc. / Activity
Activity — Lyell Immunopharma, Inc.
3 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $129.1K | +9K | 9,188 0.04% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common Stock | $10.2K | +1K | 1,155 <0.01% of shares | low |
| Q1 2026 as of | Zurcher Kantonalbank (Zurich Cantonalbank) 13F manager | New | Common Stock | $9.0K | +447 | 447 <0.01% of shares | low |